Qisda (TWSE: 2352) officially launched BenQ Medical Center Hong Kong IPO Plan today. To expand the group's medical services business, increase revenue, and achieve profit growth, the board of directors has approved that the application plan for listing its hospital business in Hong Kong. This move is expected to accelerate future growth momentum.

The Board of Directors resolved that the subsidiary BenQ BM Holding Cayman Corp. (referred to as "BBHC", aka BenQ Medical Center) applies for listing on the Main Board of the Stock Exchange of Hong Kong Limited (referred to as “SEHK”). The company will seek shareholder approval at the Extraordinary Shareholders' Meeting on March 14th. 

BBHC is the largest entity within the Qisda healthcare business field. It currently owns two large comprehensive teaching hospitals, Nanjing BenQ Medical Center, and Suzhou BenQ Medical Center. It also invests in Donghui Hospital in Guigang, Guangxi. Due to its proximity to frontline medical, nursing, and patient needs, it serves as the flagship institution guiding the group's healthcare strategic direction.

Nanjing BenQ Medical Center

Qisda pointed out that after the BBHC listing, BBHC will be able to raise funds through various financing channels, which will enhance its working capital and optimize the financial structure. This enables further expansion of hospital facilities, such as increasing the number of beds and introducing specialized medical teams and equipment. BBHC’s public offering in the listing will enhance its visibility in the industry and attract outstanding talents. It will be favorable for the Group’s increase in revenue and profits, so as to pursue the best interests of shareholders.

Suzhou BenQ Medical Center